Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V P Zherdev

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Eksperimental'Naia I Klinicheskaia Farmakologiia|October 18, 2014
[Pharmacokinetics of three peroral dosage forms of new dipeptide anxiolytic drug GB-115]E V Ivannikova, S S Boĭko, V P Zherdev, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|June 11, 2004
[Pharmacokinetics of mifepristone and kinetics of chorionic gonadotropin beta-subunit (beta-HCG) and progesterone in plasma of pregnant women during pharmacological interruption of early pregnancy]V I Kulakov, D V Zherdev, A K Sariev, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|March 1, 1996
[The use of the HPLC method for the quantitative determination of a peptide analog of piracetam with nootropic activity and its main metabolites]S S Boĭko, V P Zherdev, T A Gudasheva, et al.
Biulleten' Eksperimental'Noi Biologii I Meditsiny|October 1, 1990
[Emoxipin pharmacokinetics in normal conditions and in models of experimental pathology]E V Mishina, N G Filippenko, V V Pichugin, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|August 1, 2009
[Experimental pharmacokinetics of the new neurotensine-derived antipsychotic drug dilept]V P Zherdev, S S Boĭko, N V Mesonzhnik, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|February 27, 2010
[Comparative pharmacokinetics of dihydroquercetin in rats upon peroral administration of a parent compound and liposomal flamen D]V P Zherdev, G B Kolyvanov, A A Litvin, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|December 17, 1998
[The pharmacokinetics and metabolism of heptapeptide--a prospective synthetic analog of tuftsin with psychostimulating action in rats]S S Boĭko, V P Zherdev, A A Dvorianinov, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|March 29, 2016
[EXPERIMENTAL PHARMACOKINETICS AND PHARMACODYNAMICS OF GB-115 DIPEPTIDE ANXIOLYTIC SUBSTANCES]L G Kolik, V P Zherdev, S S Boiko, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|March 1, 1997
[The pharmacokinetics of the dipeptide analog of piracetam with nootropic activity GVS-111 and of its basic metabolites]S S Boĭko, V P Zherdev, A A Dvorianinov, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|March 1, 1997
[A comparative study of the permeability across the hemato-encephalic barrier and of the effect on cerebral blood flow of the new neurotropic agent calcium ketohomopantothenate and of pantogam]N M Nasybullina, V I Gunar, V P Zherdev, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Eksperimental'Naia I Klinicheskaia Farmakologiia|October 18, 2014
[Pharmacokinetics of three peroral dosage forms of new dipeptide anxiolytic drug GB-115]E V Ivannikova, S S Boĭko, V P Zherdev, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|June 11, 2004
[Pharmacokinetics of mifepristone and kinetics of chorionic gonadotropin beta-subunit (beta-HCG) and progesterone in plasma of pregnant women during pharmacological interruption of early pregnancy]V I Kulakov, D V Zherdev, A K Sariev, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|March 1, 1996
[The use of the HPLC method for the quantitative determination of a peptide analog of piracetam with nootropic activity and its main metabolites]S S Boĭko, V P Zherdev, T A Gudasheva, et al.
Biulleten' Eksperimental'Noi Biologii I Meditsiny|October 1, 1990
[Emoxipin pharmacokinetics in normal conditions and in models of experimental pathology]E V Mishina, N G Filippenko, V V Pichugin, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|August 1, 2009
[Experimental pharmacokinetics of the new neurotensine-derived antipsychotic drug dilept]V P Zherdev, S S Boĭko, N V Mesonzhnik, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|February 27, 2010
[Comparative pharmacokinetics of dihydroquercetin in rats upon peroral administration of a parent compound and liposomal flamen D]V P Zherdev, G B Kolyvanov, A A Litvin, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|December 17, 1998
[The pharmacokinetics and metabolism of heptapeptide--a prospective synthetic analog of tuftsin with psychostimulating action in rats]S S Boĭko, V P Zherdev, A A Dvorianinov, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|March 29, 2016
[EXPERIMENTAL PHARMACOKINETICS AND PHARMACODYNAMICS OF GB-115 DIPEPTIDE ANXIOLYTIC SUBSTANCES]L G Kolik, V P Zherdev, S S Boiko, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|March 1, 1997
[The pharmacokinetics of the dipeptide analog of piracetam with nootropic activity GVS-111 and of its basic metabolites]S S Boĭko, V P Zherdev, A A Dvorianinov, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|March 1, 1997
[A comparative study of the permeability across the hemato-encephalic barrier and of the effect on cerebral blood flow of the new neurotropic agent calcium ketohomopantothenate and of pantogam]N M Nasybullina, V I Gunar, V P Zherdev, et al.
Pageof 10